PetMed Express (NASDAQ:PETS) Share Price Passes Above 200-Day Moving Average – Here’s Why

PetMed Express, Inc. (NASDAQ:PETS) crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $4.33 and traded as high as $4.50. PetMed Express shares last traded at $4.48, with a volume of 327,233 shares changing hands.

Analyst Ratings Changes

Separately, StockNews.com downgraded PetMed Express from a “buy” rating to a “hold” rating in a research report on Tuesday, February 11th.

PetMed Express Price Performance

The company has a market capitalization of $92.56 million, a PE ratio of 448.45 and a beta of 0.70. The company’s fifty day moving average is $5.02 and its 200-day moving average is $4.33.

PetMed Express (NASDAQ:PETS) last announced its quarterly earnings results on Monday, February 10th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.02). PetMed Express had a net margin of 0.14% and a return on equity of 0.37%. Equities research analysts forecast that PetMed Express, Inc. will post 0.19 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Leslie C.G. Campbell bought 15,000 shares of the stock in a transaction on Wednesday, December 4th. The stock was bought at an average cost of $5.38 per share, for a total transaction of $80,700.00. Following the completion of the purchase, the director now directly owns 70,000 shares in the company, valued at approximately $376,600. The trade was a 27.27 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.10% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On PetMed Express

Several hedge funds have recently modified their holdings of the stock. R Squared Ltd purchased a new position in shares of PetMed Express in the fourth quarter worth $31,000. Quarry LP purchased a new stake in shares of PetMed Express in the fourth quarter worth about $47,000. Virtu Financial LLC purchased a new position in PetMed Express during the fourth quarter valued at approximately $58,000. Boothbay Fund Management LLC acquired a new position in PetMed Express in the fourth quarter valued at approximately $59,000. Finally, Squarepoint Ops LLC boosted its position in PetMed Express by 41.4% in the 4th quarter. Squarepoint Ops LLC now owns 17,686 shares of the company’s stock worth $85,000 after purchasing an additional 5,180 shares in the last quarter. Institutional investors and hedge funds own 73.33% of the company’s stock.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.